Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Zhang

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Frontiers in Neurology|October 18, 2019
Peripheral Innate Immune Activation Correlates With Disease Severity in <i>GRN</i> HaploinsufficiencyPeter A Ljubenkov, Zachary Miller, Paige Mumford, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
JBMR Plus|May 7, 2025
Monocytes/macrophages contamination disrupts functional and transcriptional characteristics of murine bone marrow- and bone-derived stromal cellsYuko Kawano, Hiroki Kawano, Stephanie Busch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid CellsPrajwal Rajappa, William S Cobb, Emma Vartanian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full AgonistSean P Brown, Paul J Dransfield, Marc Vimolratana, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2015
Discovery of the imidazole-derived GPR40 agonist AM-3189Zhihua Ma, Daniel C-H Lin, Rajiv Sharma, et al.
Molecular and Cellular Endocrinology|February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of GPR40 Agonists for Type 2 DiabetesJiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Frontiers in Neurology|October 18, 2019
Peripheral Innate Immune Activation Correlates With Disease Severity in <i>GRN</i> HaploinsufficiencyPeter A Ljubenkov, Zachary Miller, Paige Mumford, et al.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
JBMR Plus|May 7, 2025
Monocytes/macrophages contamination disrupts functional and transcriptional characteristics of murine bone marrow- and bone-derived stromal cellsYuko Kawano, Hiroki Kawano, Stephanie Busch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid CellsPrajwal Rajappa, William S Cobb, Emma Vartanian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full AgonistSean P Brown, Paul J Dransfield, Marc Vimolratana, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2015
Discovery of the imidazole-derived GPR40 agonist AM-3189Zhihua Ma, Daniel C-H Lin, Rajiv Sharma, et al.
Molecular and Cellular Endocrinology|February 14, 2013
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1Yumei Xiong, Gayathri Swaminath, Qiong Cao, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of GPR40 Agonists for Type 2 DiabetesJiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
Pageof 10